» Articles » PMID: 18717679

Impact of Childhood Vitiligo on Adult Life

Overview
Journal Br J Dermatol
Specialty Dermatology
Date 2008 Aug 23
PMID 18717679
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The onset of vitiligo occurs before the age of 20 years in 50% of patients. Having a chronic disease in childhood can impede a child's health-related quality of life (HRQL).

Objectives: Firstly, to compare the social and psychosexual development and current HRQL of young adult patients with childhood vitiligo with those of a group of healthy controls. Secondly, to compare these outcomes in patients reporting negative childhood experiences with those of patients not reporting negative childhood experiences.

Methods: Eligible patients were mailed questionnaires on (i) sociodemographic and clinical characteristics, (ii) social and psychosexual development, (iii) generic and dermatology-specific HRQL, (iv) presence of negative childhood experiences related to vitiligo, (v) specification of these negative experiences and (vi) patients' recommendations for further care.

Results: A total of 232 patients with vitiligo completed the questionnaires. Social and psychosexual development and generic HRQL in young adult patients with childhood vitiligo were not different from those of healthy controls. However, patients reporting negative childhood experiences reported significantly more problems in social development than those not reporting negative experiences. Furthermore, negative childhood experiences were significantly associated with more HRQL impairment in early adulthood.

Conclusions: Reporting negative experiences from childhood vitiligo appears to be associated with HRQL impairment in young adults with vitiligo.

Citing Articles

Prevalence of psychiatric comorbidities and treatment initiation in African American pediatric patients with vitiligo: A retrospective, single-center, case-control study.

Strouphauer E, Suhail S, Mulinda C, Ufomadu P, Nyamongo N, Lee G JAAD Int. 2024; 17:104-110.

PMID: 39399340 PMC: 11471237. DOI: 10.1016/j.jdin.2024.07.012.


Clinical Features of Vitiligo and Social Impact on Quality of Life.

Seneschal J Dermatol Pract Concept. 2024; 13(4S2).

PMID: 38241394 PMC: 10824319. DOI: 10.5826/dpc.1304S2a312S.


Global clinicoepidemiological pattern of childhood vitiligo: a systematic review and meta-analysis.

Farajzadeh S, Khalili M, Mirmohammadkhani M, Paknazar F, Rastegarnasab F, Abtahi-Naeini B BMJ Paediatr Open. 2023; 7(1).

PMID: 37616066 PMC: 10083860. DOI: 10.1136/bmjpo-2022-001839.


Prevalence of Vitiligo among Children and Adolescents in the United States.

Patel R, Pandya A, Sikirica V, Gandhi K, Daniel S, Anastassopoulos K Dermatology. 2023; 239(2):227-234.

PMID: 36630928 PMC: 10210084. DOI: 10.1159/000528180.


Chemical Profiling of Kaliziri Injection and Quantification of Six Caffeoyl Quinic Acids in Beagle Plasma by LC-MS/MS.

Liu C, Wahefu A, Lu X, Abdulla R, Dou J, Zhao H Pharmaceuticals (Basel). 2022; 15(6).

PMID: 35745582 PMC: 9230828. DOI: 10.3390/ph15060663.